# Dose Finding Study of BI 836880 in Patients With Solid Tumors

> **NCT02674152** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 29 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BI 836880

## Key facts

- **NCT ID:** NCT02674152
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-05
- **Primary completion:** 2018-09-12
- **Final completion:** 2020-11-04
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02674152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02674152, "Dose Finding Study of BI 836880 in Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02674152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*